OccuLogix IPO Nursed By A Lot Of TLC; Proceeds Will Fund Eye Surgery Study
This article was originally published in The Gray Sheet
Executive Summary
OccuLogix, Inc. will seek a Medicare national coverage determination for itsRheo plasma pump-and-filter system to treat "dry" age-related macular degeneration (AMD) upon FDA approval